Tactiva Therapeutics
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
701 Ellicott St Fl 4, Buffalo, New York,...Phone Number
(716) 536-2971Website
www.tactivatherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Tactiva Therapeutics
Tactiva Therapeutics is an immuno-oncology company focused on developing innovative cancer immunotherapy through a dual T cell receptor approach. Their Next Generation adoptive cell therapy strategies aim to deliver effective and sustained immune responses against tumors by utilizing both CD8 and CD4 T cell receptors. The company has created a library of T cell receptors that enhance the anti-tumor function and provide a long-term source of cancer-fighting T cells through the reprogramming of hematopoietic stem cells. Tactiva Therapeutics targets solid tumors, offering a promising solution for durable remission in cancer patients.Explore more
Tactiva Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tactiva Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Tactiva Therapeutics is spiking on competitors!
Product Launch: Get notified when Tactiva Therapeutics launches new products
Click to see if Tactiva Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Tactiva Therapeutics recently announced quarterly report
Tactiva Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Tactiva Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Tactiva Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Tactiva Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Tactiva Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Tactiva Therapeutics
Compare insights from companies similar to Tactiva Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tactiva Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tactiva Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tactiva Therapeutics.
Tactiva Therapeutics financials insights
Gather financial insights about Tactiva Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$35M
Tactiva Therapeutics Tech Stack
A closer look at the technologies used by Tactiva Therapeutics
See more technologies
Tactiva Therapeutics News & Media
Tactiva Therapeutics Secures $35M Series A
BUFFALO, NY, Tactiva Therapeutics has secured a $35 million Series A financing.Tactiva Therapeutics Co-Founder Kunle Odunsi Elected to National Academy of Medicine
BUFFALO, N.Y., Oct. 18, 2018 /PRNewswire/ -- Tactiva Therapeutics, a development stage company targeting a broad range of cancers, announced today that its co-founder Kunle Odunsi, M.D., Ph.D., FRCOG, FACOG, is among the 75 newly elected regular members of the National Academy of Medicine ...Tactiva Therapeutics to Present at Biotech Showcase 2018
BUFFALO, N.Y., Dec. 14, 2017 /PRNewswire/ -- Tactiva Therapeutics, Inc., a development stage company targeting a broad range of cancers, announced today that management will present at Biotech Showcase 2018 to be held in San Francisco, California January 8-10, 2018. Matt...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tactiva Therapeutics
Sign Up For FreeTo access detailed company insights
Tactiva Therapeutics is an immuno-oncology company focused on developing innovative cancer immunotherapy through a dual T cell receptor approach. Their Next Generation adoptive cell therapy strategies aim to deliver effective and sustained immune responses against tumors by utilizing both CD8 and CD4 T cell receptors. The company has created a libr... Read More
